Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | Exec. VP, Operations | October 12, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,984 |
Reported balance
After 2026-10-12 transaction · row 1
1 source rowRow 1 · 2026-10-12 · Exercise / conversion · Acquired 3,000 · Balance 70,984 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $166.73 · Expires 2026-10-27 | Direct | 3,028 |
Reported balance
After 2026-10-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-12 · Exercise / conversion · Disposed 3,000 · Balance 3,028 F1: The option vested in full on October 27, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vested in full on October 27, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 14, 2026 20:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001677418-26-000014 · wk-form4_1792008859.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,028 Underlying: Common Stock · 3,000 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| October 12, 2026 Filed Oct 14, 2026 20:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,000 | $166.73 | $500,190.00 |
DisclosureSEC source: 0001677418-26-000014 · wk-form4_1792008859.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2026 Filed Oct 9, 2026 20:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001677418-26-000012 · wk-form4_1791576873.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,028 Underlying: Common Stock · 2,000 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| October 07, 2026 Filed Oct 9, 2026 20:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 2,000 | $166.73 | $333,460.00 |
DisclosureSEC source: 0001677418-26-000012 · wk-form4_1791576873.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001677418-26-000010 · wk-form4_1789677327.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,028 Underlying: Common Stock · 3,000 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:35 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,000 | $166.73 | $500,190.00 |
DisclosureSEC source: 0001677418-26-000010 · wk-form4_1789677327.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 20:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,500 | $600.00 | $4,500,000.00 |
DisclosureSEC source: 0001677418-26-000008 · wk-form4_1785357140.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,984 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001677418-26-000006 · wk-form4_1777409193.xml · derivative · entry 3 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F3 · derivative.expiration_date: The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $410.54 | $0.00 |
DisclosureSEC source: 0001677418-26-000006 · wk-form4_1777409193.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-04-24 F1 · derivative.exercise_date: The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001677418-26-000004 · wk-form4_1773953443.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,028 Underlying: Common Stock · 12,000 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 12,000 | $166.73 | $2,000,760.00 |
DisclosureSEC source: 0001677418-26-000004 · wk-form4_1773953443.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,984 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001677418-26-000002 · wk-form4_1771364585.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,984 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on February 28, 2020. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,984 | $107.93 | $1,185,503.12 |
DisclosureSEC source: 0001677418-26-000002 · wk-form4_1771364585.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001677418-25-000018 · wk-form4_1765314891.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,984 Underlying: Common Stock · 10,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on February 28, 2020. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:14 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,000 | $107.93 | $1,079,300.00 |
DisclosureSEC source: 0001677418-25-000018 · wk-form4_1765314891.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001677418-25-000016 · wk-form4_1764883271.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,984 Underlying: Common Stock · 10,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on February 28, 2020. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,000 | $107.93 | $1,079,300.00 |
DisclosureSEC source: 0001677418-25-000016 · wk-form4_1764883271.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 20,000 | $609.15 | $12,183,000.00 |
DisclosureSEC source: 0001677418-25-000014 · wk-form4_1764192141.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $607.59 to $610.92. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 15:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,000 | $605.00 | $10,890,000.00 |
DisclosureSEC source: 0001677418-25-000012 · wk-form4_1762960222.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 20:52 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,000 | $605.01 | $1,210,020.00 |
DisclosureSEC source: 0001677418-25-000010 · wk-form4_1761771136.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,500 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $605.00 to $605.13. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 26, 2025 Filed Sep 30, 2025 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001677418-25-000008 · wk-form4_1759263309.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,984 Underlying: Common Stock · 10,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on February 28, 2020. Read SEC document |
| September 26, 2025 Filed Sep 30, 2025 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,000 | $107.93 | $1,079,300.00 |
DisclosureSEC source: 0001677418-25-000008 · wk-form4_1759263309.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,000 | $480.00 | $4,800,000.00 |
DisclosureSEC source: 0001677418-25-000005 · wk-form4_1757103359.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $480.00 to $480.09. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001677418-25-000003 · wk-form4_1756411840.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,984 Underlying: Common Stock · 10,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on February 28, 2020. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,000 | $107.93 | $1,079,300.00 |
DisclosureSEC source: 0001677418-25-000003 · wk-form4_1756411840.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,500 | $450.14 | $3,376,050.00 |
DisclosureSEC source: 0001668397-25-000099 · wk-form4_1753825420.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $450.00 to $450.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,017 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000025 · wk-form4_1741641383.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,017 Underlying: Common Stock · 11,017 shares Expires 2034-03-06 F1 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001668397-24-000170 · wk-form4_1732225202.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2025-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on February 28, 2022. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 7,500 | $32.05 | $240,375.00 |
DisclosureSEC source: 0001668397-24-000170 · wk-form4_1732225202.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000153 · wk-form4_1723062132.xml · derivative · entry 3 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F3 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001668397-24-000153 · wk-form4_1723062132.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on August 5, 2019. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 50,000 | $90.65 | $4,532,500.00 |
DisclosureSEC source: 0001668397-24-000153 · wk-form4_1723062132.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,681 | $401.20 | $3,081,617.20 |
DisclosureSEC source: 0001668397-24-000123 · wk-form4_1717791433.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.98 to $402.115. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 102 | $403.00 | $41,106.00 |
DisclosureSEC source: 0001668397-24-000061 · wk-form4_1710882695.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,181 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $403.00 to $403.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:03 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,009 | $303.00 | $608,727.00 |
DisclosureSEC source: 0000892251-23-000201 · form4.xml · nonDerivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,283 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:03 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,391 | $304.15 | $3,160,422.65 |
DisclosureSEC source: 0000892251-23-000201 · form4.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,292 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $303.00 to $305.455. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| October 23, 2023 Filed Oct 25, 2023 20:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0000892251-23-000165 · form4.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on February 28, 2022. Read SEC document |
| October 23, 2023 Filed Oct 25, 2023 20:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 7,500 | $32.05 | $240,375.00 |
DisclosureSEC source: 0000892251-23-000165 · form4.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:47 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003516 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 21:19 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,400 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001567619-22-005628 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,400 shares Expires 2024-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on March 15, 2021. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 21:19 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 12,400 | $28.32 | $351,168.00 |
DisclosureSEC source: 0001567619-22-005628 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 34,060 | $0.00 Strike: $138.87 | $0.00 |
DisclosureSEC source: 0001567619-22-004861 · doc1.xml · derivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,060 Underlying: Common Stock · 34,060 shares Expires 2029-08-15 F1 · derivative.exercise_date: The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 20:26 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,185 | $192.67 | $1,384,333.95 |
DisclosureSEC source: 0001567619-21-016795 · doc1.xml · nonDerivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,783 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.88 to $193.41. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 20:26 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 55,037 | $192.16 | $10,575,909.92 |
DisclosureSEC source: 0001567619-21-016795 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,968 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.00 to $194.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,600 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001567619-21-012190 · doc1.xml · derivative · entry 6 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 Underlying: Common Stock · 7,600 shares Expires 2024-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Each option vested on March 15, 2021. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,400 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012190 · doc1.xml · derivative · entry 5 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,400 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,600 | $178.90 | $1,359,647.60 |
DisclosureSEC source: 0001567619-21-012190 · doc1.xml · nonDerivative · entry 4 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,005 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order by the Reporting Person. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $178.43 to $179.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 7,600 | $28.32 | $215,232.00 |
DisclosureSEC source: 0001567619-21-012190 · doc1.xml · nonDerivative · entry 3 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order by the Reporting Person. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,400 | $179.02 | $1,324,718.40 |
DisclosureSEC source: 0001567619-21-012190 · doc1.xml · nonDerivative · entry 2 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,005 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order by the Reporting Person. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $178.50 to $179.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 7,400 | $23.00 | $170,200.00 |
DisclosureSEC source: 0001567619-21-012190 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.